Stay updated on Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.

Latest updates to the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study record history now shows the latest revision (v3.7.0) for the page, indicating an update to the record. The older revision (v3.6.6) has been removed from the visible history.SummaryDifference0.1%

- Check38 days agoChange DetectedThe study record history shows the site revision updated to v3.6.6 (replacing v3.6.5). This reflects a software release rather than any modification to the trial data or records.SummaryDifference0.1%

- Check45 days agoChange DetectedIntroduction of a new 'Study Status' item in the history and a new version entry (version 21) dated 2026-07-24. An older entry dated 2026-05-12 was removed.SummaryDifference0.3%

- Check59 days agoChange DetectedThe study record history now includes a new revision v3.6.5 and removes the previous revision v3.6.4, indicating an update to the record.SummaryDifference0.1%

- Check73 days agoChange DetectedThe History section now shows revision v3.6.4, replacing v3.6.3. This indicates a new version of the record/history was published, updating the page's underlying revision metadata.SummaryDifference0.1%

- Check95 days agoChange DetectedThe revision label in the history table updates from v3.6.2 to v3.6.3, indicating a new revision of the study record.SummaryDifference0.1%

Stay in the know with updates to Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.